Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tefferi

Showing results (211-220 of 346) with videos related to

Pageof 35
Sort By:
Leukemia|December 16, 2006
Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patientsN Gangat, A P Wolanskyj, R F McClure, et al.
Leukemia|September 26, 2014
Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinibR A Abdelrahman, K H Begna, A Al-Kali, et al.
Leukemia|November 2, 2017
Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosisA Tefferi, T L Lasho, C Finke, et al.
Leukemia|December 1, 1990
The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemiaA Tefferi, G D Bren, K V Wagner, et al.
Mayo Clinic Proceedings|December 1, 1995
Extramedullary hematopoiesis manifesting as a symptomatic pleural effusionR P Bartlett, P R Greipp, A Tefferi, et al.
Blood|February 15, 1993
The 5q- syndrome: a single-institution study of 43 consecutive patientsP Mathew, A Tefferi, G W Dewald, et al.
British Journal of Haematology|March 1, 1997
Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cellsA Tefferi, C A Hanson, P J Kurtin, et al.
Leukemia|April 2, 2010
Trisomy 11: prevalence among 22,403 unique patient cytogenetic studies and clinical correlatesD Caramazza, R P Ketterling, R A Knudson, et al.
Leukemia|November 19, 2004
WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literatureM A Elliott, C A Hanson, G W Dewald, et al.
Leukemia Research|September 4, 1999
Treatment of unfavorable myelodysplastic syndrome with all-trans-retinoic acid and subcutaneous Ara CL Letendre, P Noel, W L White, et al.
Pageof 35

Showing results (211-220 of 346) with videos related to

Sort By:
Pageof 35
Leukemia|December 16, 2006
Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patientsN Gangat, A P Wolanskyj, R F McClure, et al.
Leukemia|September 26, 2014
Revised assessment of response and long-term discontinuation rates among 111 patients with myelofibrosis treated with momelotinib or ruxolitinibR A Abdelrahman, K H Begna, A Al-Kali, et al.
Leukemia|November 2, 2017
Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosisA Tefferi, T L Lasho, C Finke, et al.
Leukemia|December 1, 1990
The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemiaA Tefferi, G D Bren, K V Wagner, et al.
Mayo Clinic Proceedings|December 1, 1995
Extramedullary hematopoiesis manifesting as a symptomatic pleural effusionR P Bartlett, P R Greipp, A Tefferi, et al.
Blood|February 15, 1993
The 5q- syndrome: a single-institution study of 43 consecutive patientsP Mathew, A Tefferi, G W Dewald, et al.
British Journal of Haematology|March 1, 1997
Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cellsA Tefferi, C A Hanson, P J Kurtin, et al.
Leukemia|April 2, 2010
Trisomy 11: prevalence among 22,403 unique patient cytogenetic studies and clinical correlatesD Caramazza, R P Ketterling, R A Knudson, et al.
Leukemia|November 19, 2004
WHO-defined chronic neutrophilic leukemia: a long-term analysis of 12 cases and a critical review of the literatureM A Elliott, C A Hanson, G W Dewald, et al.
Leukemia Research|September 4, 1999
Treatment of unfavorable myelodysplastic syndrome with all-trans-retinoic acid and subcutaneous Ara CL Letendre, P Noel, W L White, et al.
Pageof 35